Log in
Enquire now
‌

US Patent 11767355 Methods for modulating an immune response

Patent 11767355 was granted and assigned to Cue Biopharma on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Cue Biopharma
Cue Biopharma
Current Assignee
Cue Biopharma
Cue Biopharma
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11767355
Patent Inventor Names
Rodolfo J. Chaparro
Ronald D. Seidel, III
Date of Patent
September 26, 2023
Patent Application Number
17961001
Date Filed
October 6, 2022
Patent Citations
‌
US Patent 7670595 Fc-interferon-beta fusion proteins
‌
US Patent 7098306 Method and compositions for treating hepatocellular cancer
‌
US Patent 7186804 IL-2 fusion proteins with modulated selectivity
‌
US Patent 7432351 B7-H1 variants
‌
US Patent 8992937 Disulfide trap MHC class I molecules and uses therefor
‌
US Patent 9284349 Peptide vaccines for cancers expressing tumor-associated antigens
‌
US Patent 9359424 Multimeric polypeptides of HLA-G including alpha1-alpha3 monomers and pharmaceutical uses thereof
‌
US Patent 9494588 Gene coded for a MHC class I molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a T cell frequency
...
Patent Citations Received
‌
US Patent 11993641 Methods for modulating an immune response
0
‌
US Patent 11878062 Multimeric T-cell modulatory polypeptides and methods of use thereof
0
‌
US Patent 11958893 Methods for modulating an immune response
0
‌
US Patent 11987610 T-cell modulatory multimeric polypeptides and methods of use thereof
0
Patent Primary Examiner
‌
Yan Xiao
CPC Code
‌
C12N 15/62
‌
C07K 14/70539
‌
C07K 14/79
‌
C07K 14/55
‌
C07K 16/2827
‌
A61K 9/0019
‌
A61K 47/68
‌
A61P 37/06
Patent abstract

The present disclosure provides methods of modulating an immune response in an individual. The present disclosure provides methods of treatment. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) and an immune checkpoint inhibitor to an individual. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) to an individual who is undergoing treatment with immune checkpoint inhibitor.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11767355 Methods for modulating an immune response

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.